Cargando…
Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis
Nonalcoholic steatohepatitis (NASH) is a chronic liver disease that can lead to cirrhosis, liver transplant, and even hepatocellular carcinoma. While liver biopsy remains the reference standard for disease diagnosis, analytical and clinical development of non-invasive soluble biomarkers of NASH are...
Autores principales: | Kar, Sumit, Paglialunga, Sabina, Jaycox, Sharon H., Islam, Rafiqul, Paredes, Angelo H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619600/ https://www.ncbi.nlm.nih.gov/pubmed/31291245 http://dx.doi.org/10.1371/journal.pone.0217263 |
Ejemplares similares
-
Evaluation of HbA1c screening during outreach events for prediabetes subject recruitment for clinical research
por: Paglialunga, Sabina, et al.
Publicado: (2018) -
Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021) -
Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond
por: Kar, Sumit, et al.
Publicado: (2020) -
Chemokines as inflammatory mediators of fibrosis in liver fibrosis
por: Wasmuth, H E
Publicado: (2010) -
Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
por: Fan, Weiguo, et al.
Publicado: (2021)